Author:
Pereson Matías J.,Amaya Lucas,Neukam Karin,Baré Patricia,Echegoyen Natalia,Badano María Noel,Lucero Alicia,Martelli Antonella,Garcia Gabriel H.,Videla Cristina,Martínez Alfredo P.,Di Lello Federico A.
Funder
Instituto de Salud Carlos III
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference29 articles.
1. AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets;European Medicines Agency,2021
2. COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis;European Medicines Agency,2021
3. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial;Borobia;Lancet,2021
4. mRNA vaccines enhance neutralizing immunity against SARS-CoV-2 variants in convalescent and ChAdOx1-primed subjects;Fabricius;Vaccines,2021
5. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study;Hillus;Lancet,2021